Mary Jane Osborn
American biochemist and molecular biologist

Mary Jane Osborn (September 24, 1927 – January 17, 2019) was an American biochemist and microbiologist known for her research on the biosynthesis of lipopolysaccharide (bacterial endotoxin), a key component of the outer membrane of Gram-negative bacteria, and discovering the mechanism of action of the anti-cancer drug methotrexate. She headed the Department of Molecular Biology and Biophysics at the University of Connecticut Health Center and served as president of the American Society for Biochemistry and Molecular Biology.
Early life and education
Mary Jane Merten was born on September 24, 1927, in Colorado Springs, Colorado. Her family moved to Beverly Hills, California when she was five, and her father was very supportive of her scientific interests and ambitions.
She received a bachelor's degree in physiology from the University of California at Berkeley in 1948. She then earned a Ph.D. in biochemistry from the University of Washington in 1958, where her thesis research investigated the function of folic acid-dependent enzymes and vitamins. In 1957, while working in the laboratory of F. M. Huennekens, she discovered the mechanism of action of methotrexate, a pharmaceutical drug used to treat cancer, rheumatoid arthritis, and psoriatic arthritis.
Career
After receiving her Ph.D., she began a postdoctoral microbiology fellowship at the New York University College of Medicine, and was appointed assistant professor there in 1962. In 1963, she joined the Albert Einstein College of Medicine as an assistant professor, and was promoted to associate professor in 1996.
She joined University of Connecticut School of Medicine as professor in 1968, where, as one of the founding members, she helped develop their medical school program.
“Mary Jane Osborn” enters the record as american biochemist and molecular biologist. Crown Archives preserves that source wording while asking what Mary, Jane and Osborn can confirm, complicate or overturn.
Why this record matters
“Mary Jane Osborn” is worth following because a concise public description often conceals a longer documentary argument. Here, Mary, Jane and Osborn provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jul 31, 2026. The linked authority identifier is Q17466585. 1 of 1 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1927, 2019, 1948 and 1958.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Mary Jane Osborn”, its source revision and the description used here.
- Expand the search: follow Mary Jane Osborn primary sources, Mary Jane Osborn archive and Mary research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Mary Jane Osborn”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Mary Jane Osborn” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.